atai Launches Revixia Life Sciences to Develop Salvinorin A for a Variety of Mental Health Conditions Aug 12, 2021
Strong Psychedelic Data In 1H 2021 Sets The Stage For Key Endpoint Results Later This Year Jun 23, 2021